This issue’s Views and Reviews series furthers our understanding of the phenotyping and the environmental,
genetic, and evolutionary determinants of polycystic ovary syndrome, assisting in elucidating the
fundamental etiologies underlying this common and pervasive syndrome.
The authors review the evolution of the criteria used to diagnosis polycystic ovary syndrome, the prevalence of the disorder, the distribution of polycystic ovary
syndrome phenotypes, their morbidity, and the role that referral bias plays in the epidemiology of this syndrome.
This paper reviews the current research on the role of environmental factors in the development and progression of polycystic ovary syndrome, including toxins, diet, socioeconomic status, and geography.
High-throughput disease gene mapping has identified 16 susceptibility loci for polycystic ovary syndrome and functional analysis to understand how these genes act in disease pathways will help to illuminate the pathophysiology of polycystic ovary syndrome.
Although polycystic ovary syndrome is the most common cause of anovulatory infertility, its high prevalence is an evolutionary paradox. In this article the potential explanations for this enigma are explored.
Polycystic ovary syndrome (PCOS) is a prehistoric evolutionary paradox. Although there are claims that PCOS has undergone positive selection, it is more likely that nonadaptive evolutionary mechanisms have driven its persistence across time.
Male relatives of women with polycystic ovary syndrome have a distinct reproductive phenotype. We report novel features of this phenotype including elevated antimullerian hormone, luteinizing hormone, and follicle-stimulating hormone levels.
In a cohort of 214 patients with testicular cancer, larger tumors were associated with lower rates of spermatozoa in the cancerous testis. Importantly, 58% of patients with azoospermia and cryptozoospermia had spermatozoa in their histologic
sections.
Preimplantation genetic screening performed in fresh in vitro fertilization cycles during 2011–2012 decreased chances of live birth for most patients. Older women observed small improvements, which are likely consequence of favorable patient selection biases.
Elective single-embryo transfer (eSET) is more likely with infertility treatment insurance coverage, and specific demographic and reproductive characteristics. Term non–low birth weight singleton live birth is most likely with eSET.
Although we observed a small improvement in live birth/ongoing pregnancy and clinical PRs, the evidence is of very low quality and the best interpretation is that we are still very uncertain about differences in this comparison.
Blastocyst biopsy and vitrification were associated with a higher incidence of gestational hypertension but better neonatal outcomes compared with cleavage-stage biopsy and fresh embryo transfer, especially in twins.
Nondominant small follicles are a promising supplementary source of in vivo–matured oocytes, and their use increases the live birth rate in natural cycle in vitro fertilization.
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
Cookie Control
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us
and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.